Karl Storz SE & Co. KGMarch 12, 2020

FDA 483 - Karl Storz SE & Co. KG - March 12, 2020

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Karl Storz SE & Co. KG

Record Details

An FDA inspection of Karl Storz SE & Co. KG, a medical device manufacturer in Tuttlingen, Germany, revealed significant deficiencies in their quality system. The firm failed to adequately establish procedures for complaint handling, ensure service reports contained all required information, and control environmental conditions related to electrical energy. These issues indicate systemic problems in maintaining compliance with regulatory requirements.

Company: Karl Storz SE & Co. KG
Inspection Date: March 12, 2020
Product Type: Device
Office: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)
Person: John A. Sciacchitano (investigator)

Open in Dashboard

ID · 3ee24cfc-d62e-44c9-ad4f-3835f53577e6